Adaptive Biotechnologies Corporation Common Stock (ADPT) is a publicly traded Healthcare sector company. As of May 21, 2026, ADPT trades at $14.32 with a market cap of $2.03B and a P/E ratio of -41.23. ADPT moved +7.64% today. Year to date, ADPT is -13.67%; over the trailing twelve months it is +49.15%. Its 52-week range spans $4.27 to $20.76. Analyst consensus is strong buy with an average price target of $20.17. Rallies surfaces ADPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Adaptive Biotechnologies Corporation Common Stock (ADPT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ADPT moved +7.64% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $14.32 |
| Market Cap | $2.03B |
| P/E Ratio | -41.23 |
| EPS | $-0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.76 |
| 52-Week Low | $4.27 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $295.41M |
| Net Income | $-49.64M |
| Gross Margin | 75.26% |
8 analysts cover ADPT: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.17.